290 related articles for article (PubMed ID: 32487734)
41. NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Mol Carcinog; 2012 Aug; 51(8):636-46. PubMed ID: 21837760
[TBL] [Abstract][Full Text] [Related]
42. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
[TBL] [Abstract][Full Text] [Related]
43. The acetylase/deacetylase couple CREB-binding protein/Sirtuin 1 controls hypoxia-inducible factor 2 signaling.
Chen R; Xu M; Hogg RT; Li J; Little B; Gerard RD; Garcia JA
J Biol Chem; 2012 Aug; 287(36):30800-11. PubMed ID: 22807441
[TBL] [Abstract][Full Text] [Related]
44. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
45. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells.
Minchin RF
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):1-3. PubMed ID: 7717963
[TBL] [Abstract][Full Text] [Related]
46. Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism.
Cribb AE; Nakamura H; Grant DM; Miller MA; Spielberg SP
Biochem Pharmacol; 1993 Mar; 45(6):1277-82. PubMed ID: 8466547
[TBL] [Abstract][Full Text] [Related]
47. Human acetyltransferase polymorphisms.
Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R
Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739
[TBL] [Abstract][Full Text] [Related]
48. Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1.
Walraven JM; Trent JO; Hein DW
Drug Metab Rev; 2008; 40(1):169-84. PubMed ID: 18259988
[TBL] [Abstract][Full Text] [Related]
49. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
50. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
51. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development.
Ohkawa N; Sugisaki S; Tokunaga E; Fujitani K; Hayasaka T; Setou M; Inokuchi K
Genes Cells; 2008 Nov; 13(11):1171-83. PubMed ID: 19090811
[TBL] [Abstract][Full Text] [Related]
52. Cyanamide-mediated Inhibition of N-acetyltransferase 1.
Dierolf D; Scheitza S; Bonifas J; Blömeke B
Toxicology; 2012 Dec; 302(1):1-10. PubMed ID: 22835378
[TBL] [Abstract][Full Text] [Related]
53. Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca
Gorski PA; Jang SP; Jeong D; Lee A; Lee P; Oh JG; Chepurko V; Yang DK; Kwak TH; Eom SH; Park ZY; Yoo YJ; Kim DH; Kook H; Sunagawa Y; Morimoto T; Hasegawa K; Sadoshima J; Vangheluwe P; Hajjar RJ; Park WJ; Kho C
Circ Res; 2019 Apr; 124(9):e63-e80. PubMed ID: 30786847
[TBL] [Abstract][Full Text] [Related]
54. Human N-acetylation of benzidine: role of NAT1 and NAT2.
Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
[TBL] [Abstract][Full Text] [Related]
55. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
56. Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation.
Butcher NJ; Arulpragasam A; Minchin RF
J Biol Chem; 2004 May; 279(21):22131-7. PubMed ID: 15039438
[TBL] [Abstract][Full Text] [Related]
57. Identification of a novel allele at the human NAT1 acetyltransferase locus.
Doll MA; Jiang W; Deitz AC; Rustan TD; Hein DW
Biochem Biophys Res Commun; 1997 Apr; 233(3):584-91. PubMed ID: 9168895
[TBL] [Abstract][Full Text] [Related]
58. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
Butcher NJ; Ilett KF; Minchin RF
Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
[TBL] [Abstract][Full Text] [Related]
59. The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation.
Kong S; Kim SJ; Sandal B; Lee SM; Gao B; Zhang DD; Fang D
J Biol Chem; 2011 May; 286(19):16967-75. PubMed ID: 21454709
[TBL] [Abstract][Full Text] [Related]
60. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
